1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. CXO Perspective
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. SALMONELLA TESTING AND TREATMENT MARKET BY TESTING METHOD
5.1. Introduction
5.2. Culture-based Methods
5.3. Molecular-based Methods
5.4. Immunoassay
6. SALMONELLA TESTING AND TREATMENT MARKET BY TREATMENT METHOD
6.1. Introduction
6.2. Antibiotic Treatment
6.3. Supportive Care
6.4. Vaccination
6.5. Others
7. SALMONELLA TESTING AND TREATMENT MARKET BY END-USER
7.1. Introduction
7.2. Food Industry
7.3. Healthcare
7.4. Agriculture and Animal Husbandry
7.5. Others
8. SALMONELLA TESTING AND TREATMENT MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Testing Method
8.2.2. By Treatment Method
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Testing Method
8.3.2. By Treatment Method
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Testing Method
8.4.2. By Treatment Method
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Testing Method
8.5.2. By Treatment Method
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Testing Method
8.6.2. By Treatment Method
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. South Korea
8.6.4.4. Australia
8.6.4.5. India
8.6.4.6. Indonesia
8.6.4.7. Thailand
8.6.4.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific Inc.
10.2. Merck KGaA
10.3. Gold Standard Diagnostics
10.4. Romer Labs
10.5. BD
10.6. Pfizer Inc.
10.7. Agilent Technologies Inc.
10.8. Eurofins Scientific
10.9. QIAGEN
10.10. Bio-Rad Laboratories Inc.